| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MyMD Pharmaceuticals Inc (NASDAQ: MYMD)
MYMD Technical Analysis
5
| As on 9th Jun 2023 MYMD STOCK Price closed @ 1.57 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.59 & Strong Sell for SHORT-TERM with Stoploss of 4.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MYMDSTOCK Price
| Open | 1.60 | Change | Price | % |
| High | 1.63 | 1 Day | -0.02 | -1.26 |
| Low | 1.52 | 1 Week | -0.60 | -27.65 |
| Close | 1.57 | 1 Month | -0.29 | -15.59 |
| Volume | 347167 | 1 Year | -4.88 | -75.66 |
| 52 Week High 6.76 | 52 Week Low 0.92 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MYMD Daily Charts |
MYMD Intraday Charts |
Whats New @ Bazaartrend |
MYMD Free Analysis |
|
|
MYMD Important Levels Intraday
| RESISTANCE | 1.78 |
| RESISTANCE | 1.71 |
| RESISTANCE | 1.67 |
| RESISTANCE | 1.63 |
| SUPPORT | 1.51 |
| SUPPORT | 1.47 |
| SUPPORT | 1.43 |
| SUPPORT | 1.36 |
MYMD Forecast May 2024
| 4th UP Forecast | 5.44 |
| 3rd UP Forecast | 4.2 |
| 2nd UP Forecast | 3.43 |
| 1st UP Forecast | 2.67 |
| 1st DOWN Forecast | 0.47 |
| 2nd DOWN Forecast | -0.29 |
| 3rd DOWN Forecast | -1.06 |
| 4th DOWN Forecast | -2.3 |
MYMD Weekly Forecast
| 4th UP Forecast | 4.54 |
| 3rd UP Forecast | 3.59 |
| 2nd UP Forecast | 3.00 |
| 1st UP Forecast | 2.41 |
| 1st DOWN Forecast | 0.73 |
| 2nd DOWN Forecast | 0.14 |
| 3rd DOWN Forecast | -0.45 |
| 4th DOWN Forecast | -1.40 |
MYMD Forecast2024
| 4th UP Forecast | 12.92 |
| 3rd UP Forecast | 9.28 |
| 2nd UP Forecast | 7.03 |
| 1st UP Forecast | 4.78 |
| 1st DOWN Forecast | -1.64 |
| 2nd DOWN Forecast | -3.89 |
| 3rd DOWN Forecast | -6.14 |
| 4th DOWN Forecast | -9.78 |
MyMD Pharmaceuticals Inc ( NASDAQ USA Symbol : MYMD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MYMD Business Profile
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, engages in the development of drug candidates to treat autoimmune, and aging and age-related diseases. It is developing MYMD-1, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel diseases, as well as to treat age-related illnesses such as, frailty and sarcopenia. The company is also developing Supera-CBD, a synthetic preclinical cannabidiol derivative that targets CB2 receptors. The company is based in Baltimore, Maryland. Address: 855 North Wolfe Street, Baltimore, MD, United States, 21205
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service